148 related articles for article (PubMed ID: 11192465)
1. Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid.
Wax PM; Thornton CA
J Toxicol Clin Toxicol; 2000; 38(7):777-80. PubMed ID: 11192465
[TBL] [Abstract][Full Text] [Related]
2. Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate.
Lu PH; Tseng JC; Chen CK; Chen CH
J Clin Pharm Ther; 2017 Aug; 42(4):506-508. PubMed ID: 28547870
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water.
Guha Mazumder DN; De BK; Santra A; Ghosh N; Das S; Lahiri S; Das T
J Toxicol Clin Toxicol; 2001; 39(7):665-74. PubMed ID: 11778664
[TBL] [Abstract][Full Text] [Related]
4. Electroanalytical and isothermal calorimetric study of As(III) complexation by the metal poisoning remediators, 2,3-dimercapto-1-propanesulfonate and meso-2,3-dimercaptosuccinic acid.
Cavanillas S; Chekmeneva E; Ariño C; Díaz-Cruz JM; Esteban M
Anal Chim Acta; 2012 Oct; 746():47-52. PubMed ID: 22975179
[TBL] [Abstract][Full Text] [Related]
5. Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid).
Stenehjem AE; Vahter M; Nermell B; Aasen J; Lierhagen S; Mørland J; Jacobsen D
Clin Toxicol (Phila); 2007 May; 45(4):424-8. PubMed ID: 17486487
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid.
Tadlock CH; Aposhian HV
Biochem Biophys Res Commun; 1980 May; 94(2):501-7. PubMed ID: 6249288
[No Abstract] [Full Text] [Related]
7. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
[No Abstract] [Full Text] [Related]
8. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
Bjørklund G; Mutter J; Aaseth J
Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
[TBL] [Abstract][Full Text] [Related]
9. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.
Flora SJ; Bhadauria S; Pant SC; Dhaked RK
Life Sci; 2005 Sep; 77(18):2324-37. PubMed ID: 15964026
[TBL] [Abstract][Full Text] [Related]
10. Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid.
Aposhian HV
Adv Enzyme Regul; 1982; 20():301-19. PubMed ID: 6287818
[TBL] [Abstract][Full Text] [Related]
11. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
[TBL] [Abstract][Full Text] [Related]
12. Arsenic and lead induced free radical generation and their reversibility following chelation.
Flora SJ; Flora G; Saxena G; Mishra M
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
14. Arsenic toxicology: five questions.
Aposhian HV; Aposhian MM
Chem Res Toxicol; 2006 Jan; 19(1):1-15. PubMed ID: 16411650
[No Abstract] [Full Text] [Related]
15. 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.
Hruby K; Donner A
Med Toxicol Adverse Drug Exp; 1987; 2(5):317-23. PubMed ID: 3312928
[No Abstract] [Full Text] [Related]
16. Chronic arsenic poisoning: A sinister cause of peripheral neuropathy in a young couple.
Prakash PR; Narayan A; Jain S; Wig N
J Postgrad Med; 2024 Apr; 70(2):105-108. PubMed ID: 38629272
[TBL] [Abstract][Full Text] [Related]
17. Arsenic intoxication presenting with macrocytosis and peripheral neuropathy, without anemia.
Heaven R; Duncan M; Vukelja SJ
Acta Haematol; 1994; 92(3):142-3. PubMed ID: 7871953
[TBL] [Abstract][Full Text] [Related]
18. DMSA, DMPS, and DMPA--as arsenic antidotes.
Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
[TBL] [Abstract][Full Text] [Related]
19. Intentional overdose of dimercaptosuccinic acid in the course of treatment for arsenic poisoning.
Buchwald AL
J Toxicol Clin Toxicol; 2001; 39(1):113-4. PubMed ID: 11327220
[No Abstract] [Full Text] [Related]
20. The use of haemodialysis and 2,3 propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide.
Kruszewska S; Wiese M; Kołaciński Z; Mielczarska J
Int J Occup Med Environ Health; 1996; 9(2):111-5. PubMed ID: 8803325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
